QT
IRLA

Quantamental Technologies’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Quantamental Technologies’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-54
Closed -$17K – 613
2023
Q1 		$17K Sell
54
-5
-8% -$978 0.01% 406
2022
Q4 		$7.5K Hold
59
– – ﹤0.01% 434
2022
Q3 		$16K Sell
59
-2
-3% -$762 0.01% 477
2022
Q2 		$27K Sell
61
-2
-3% -$1.41K 0.01% 398
2022
Q1 		$78K Sell
63
-3
-5% -$4.08K 0.05% 347
2021
Q4 		$167K Buy
+66
New +$403K 0.08% 346

Other funds holding IRLA

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantamental Technologies's IRLA Position: Q2 2023 in Review

Quantamental Technologies sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2023, closing a stake of 54 shares — an estimated $17K sold.

Quantamental Technologies first reported a position in IRLA in Q4 2021 and held it in 6 quarters. The position peaked at $167K in Q4 2021. 38 funds tracked by Wall St. Rank hold IRLA as of Q2 2023.

  • Quantamental Technologies reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 54 IRulya Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $17K.
  • Quantamental Technologies first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Quantamental Technologies's IRulya Therapeutics Inc. Common Stock position peaked at $167K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.